Perk Labs Inc.
PERK
CNSX
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 78.57% | 517.02% | -71.83% | 72.92% | -19.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 78.57% | 517.02% | -71.83% | 72.92% | -19.23% |
| Cost of Revenue | 109.38% | 491.84% | -54.17% | 164.00% | 0.00% |
| Gross Profit | -30.00% | 100.00% | -80.85% | -26.09% | -50.00% |
| SG&A Expenses | -4.21% | 6.66% | -96.67% | -13.46% | -3.79% |
| Depreciation & Amortization | -95.11% | -33.69% | -5.88% | -7.37% | -28.40% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.60% | -1.86% | -79.73% | -33.38% | -14.46% |
| Operating Income | 9.35% | 6.35% | 79.84% | 34.18% | 14.42% |
| Income Before Tax | 35.75% | 57.46% | 78.58% | 19.49% | 20.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 35.75% | 57.46% | 78.58% | 19.49% | 20.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.75% | 57.46% | 78.58% | 19.49% | 20.35% |
| EBIT | 9.35% | 6.35% | 79.84% | 34.18% | 14.42% |
| EBITDA | 5.99% | 3.17% | 79.14% | 34.19% | 13.76% |
| EPS Basic | 69.44% | 79.69% | 82.76% | 27.59% | 26.53% |
| Normalized Basic EPS | 56.25% | 55.56% | 83.33% | 48.00% | 20.00% |
| EPS Diluted | 69.44% | 83.54% | 82.76% | -86.21% | 55.00% |
| Normalized Diluted EPS | 62.50% | 58.82% | 82.35% | 48.00% | 20.00% |
| Average Basic Shares Outstanding | 114.93% | 114.59% | 12.05% | 11.72% | 9.29% |
| Average Diluted Shares Outstanding | 142.61% | 123.98% | 6.56% | 11.72% | 9.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |